Nolomirole hydrochloride

Drug Profile

Nolomirole hydrochloride

Alternative Names: CHF 1035

Latest Information Update: 09 Jan 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi
  • Class Cardiotonics; Small molecules; Tetrahydronaphthalenes; Vasodilators
  • Mechanism of Action Alpha 2 adrenergic receptor agonists; Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure

Most Recent Events

  • 09 Jan 2002 CHF 1035 is now called Nolomirole hydrochloride
  • 14 Nov 2000 A clinical study has been added to the Heart Failure pharmacodynamics section
  • 20 Feb 1997 Company Communication added to the heart failure pharmacodynamics, pharmacokinetics and adverse effects sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top